(Nanowerk News) Take a millionth of a human brain and squeeze it into a special chamber the size of a mustard seed. Link it to a second chamber filled with cerebral spinal fluid and thread both of ...
—Combines Three Leading Live Biomimetic Organoid Platforms Designed to Make R&D for Neurological Diseases Faster, More Efficient and More Successful— —AxoSim Gains Expert Scientific Team and Advanced ...
—AxoSim Gains microBrain™ Intellectual Property from StemoniX, Along With Expert Scientific Team and Advanced R&D and Manufacturing Facility in Minnesota— —AxoSim to Begin Offering microBrain Products ...
New Orleans biotech startup AxoSim, Inc. reached an agreement in July with Vyant Bio, Inc. to acquire the microBrain-associated assets of its StemoniX subsidiary. Effective immediately, AxoSim will ...
StemoniX Finds Billion-Cell Lots Enhance the Consistency of Toxicity Testing Operations The microHeart ® and microBrain ® microtissues developed by StemoniX overcome many of the challenges associated ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Vyant has been exploring ...
MAPLE GROVE, Minn., Jan. 27, 2020 /PRNewswire/ -- StemoniX, a biotech company revolutionizing how new medicines are discovered, announced today that its Director of Applications, Oivin Guichert, Ph.D.
As Vyant Bio continues its wind-down, the neuroscience research assets of its subsidiary StemoniX have officially been picked up by AxoSim, a New Orleans-based drug discovery biotech. In an Oct. 24 ...
This is an artist's conception of the microbrain bioreactor. The upper chamber contains the neurons and an artificial capillary that carries blood to the brain surrounded by the cells that make up the ...
Take a millionth of a human brain and squeeze it into a special chamber the size of a mustard seed. Link it to a second chamber filled with cerebral spinal fluid and thread both of them with ...
—Combines Three Leading Live Biomimetic Organoid Platforms Designed to Make R&D for Neurological Diseases Faster, More Efficient and More Successful— —AxoSim Gains Expert Scientific Team and Advanced ...